Maria Sharapova announces she failed a drug test at the Australian Open

Big news in the tennis world.
(Image credit: Screenshot/YouTube)

Russian professional tennis player Maria Sharapova announced Monday that she had failed a drug test at the Australian Open in January. Sharapova, who has been plagued recently by injuries, told the press that the drug was Meldonium, which she had been taking for 10 years. Meldonium was put on a banned substance list at the beginning of the year; Sharapova said she hadn't known. The drug reportedly helps increase endurance in athletes and helps with rehabilitation. Sharapova has been the highest-paid female athlete for 11 straight years.

"I don't want to end my career this way," Sharapova said at the press conference, in reference to rumors that her announcement was going to be about retirement. "I really hope I'll be given another chance to play this game."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Jeva Lange

Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.